Neuroimaging Techniques

Chapter 13


Neuroimaging Techniques



Normal sleep has been explored with functional brain imaging techniques to characterize the distribution of brain activity across and within the various stages of sleep. Positron emission tomography (PET) shows the neural distribution of compounds labeled with positron- emitting isotopes. For instance, PET using oxygen-15 labeled water (H215O) gives an assessment of regional cerebral blood flow (rCBF), whereas PET with fluorodeoxyglucose (18F-FDG) measures cerebral metabolic rate of glucose (CMRglu). PET has been repeatedly used in the past 2 decades to compare brain perfusion or glucose metabolism patterns between different stages of sleep and wakefulness. More recently, functional magnetic resonance imaging (fMRI) has also been used to study brain activity during sleep. This technique measures the variations in brain perfusion related to neural activity by assessing the blood oxygen level–dependent (BOLD) signal. The latter relies on the relative decrease in deoxyhemoglobin concentration that follows the local increase in cerebral blood flow in an activated brain area. Although improvements have been made in the spatial resolution of PET, fMRI still benefits from a superior temporal resolution, which has allowed investigators to assess with fMRI brain activations related to specific neural oscillations within sleep stages and thus to characterize the neural correlates of sleep microarchitecture.


Sleep disorders have also been subject to a variety of neuroimaging studies, which have brought important insight into the pathophysiological characteristics of these disorders. Various imaging modalities have been used. They include neuroanatomical studies using magnetic resonance imaging (MRI) to analyze changes in brain structure with voxel-based morphometry (VBM), white matter changes with diffusion tensor imaging (DTI), or neuronal integrity with proton magnetic resonance spectroscopy (1H-MRS). Transcranial sonography (TCS) is used to detect local iron content and signs of neurodegeneration in brainstem structures. Functional neuroimaging studies involve PET or fMRI, as described earlier, but also single-photon emission computed tomography (SPECT). The latter shows the neural distribution of a gamma-emitting radioisotope usually attached to a particular radioligand with specific chemical binding properties. For example, SPECT with Technetium 99mTc ethyl cysteinate dimer (99mTc ECD) or 99mTc hexamethylpropyleneamine oxime (99mTc-HMPAO) evaluates the distribution of brain perfusion. Functional neuroimaging studies in sleep disorders have assessed brain responses throughout the sleep-wake cycle (during wakefulness in most of the cases) or in association with symptomatic events. Finally, SPECT and PET were also coupled with specific radioligands to evaluate regional neurotransmitter function, particularly for dopamine (DA).


Among sleep disorders that have been assessed with neuroimaging studies are obstructive sleep apnea (OSA), narcolepsy, restless legs syndrome (RLS), often associated with periodic limb movements (PLM) in sleep, parasomnias taking place either during rapid eye movement (REM) sleep (REM sleep behavior disorder [RBD]) or non-REM sleep (such as sleepwalking), and insomnia. A summary of brain imaging findings and representative figures will be provided for each of these clinical conditions.


It should be emphasized that acquiring neuroimaging data in patients with sleep disorders constitutes a technical challenge. In many of these disorders, the occurrence of movements—usually unpredictable—during image acquisition is likely to produce artifacts for both structural and functional procedures. Techniques such as SPECT, for instance, allow scan acquisition to be performed well after the radiolabeled compound has been injected during the period of interest, thus reducing the interference of movements with the imaging procedure.



Normal Sleep


PET studies demonstrated a global decrease of CMRglu (>40%) during non-REM sleep as compared to wakefulness. At the regional level, mostly decreases of CMRglu and rCBF were observed during non-REM sleep, in various subcortical structures and associative cortical areas. REM sleep, on the other hand, displayed a global CMRglu as high as during wakefulness. Locally, increases and decreases of CMRglu and rCBF were reported in areas responsible for the generation of REM sleep and some important characteristics of dreams. Beyond sleep stages, fMRI studies described neural responses associated with brain oscillations of sleep: spindles and slow waves during non-REM sleep, and ponto-geniculo-occipital waves during REM sleep. Besides refining the characterization of sleep functional neuroanatomy, fMRI data also demonstrated that non-REM sleep is not merely a passive state of brain deactivation, by showing enhanced brain responses associated with spindles and slow waves.



Non-REM Sleep


At the subcortical level, localized decreases of rCBF during non-REM sleep, as compared to wakefulness and REM sleep, were observed in the brainstem, thalamus, basal ganglia, and basal forebrain.1 These structures include groups of neurons critical for the modulation of arousal and the generation of spontaneous neural oscillations of sleep. At the cortical level, although rCBF in primary cortices remained relatively preserved, decreases were located in several associative areas: (medial) prefrontal cortex, anterior and posterior cingulate gyrus, and precuneus. These areas are highly active in wakefulness, during which they are involved in complex cognitive processes and also participate in the modulation of non-REM sleep oscillations (see later). A representation of these PET results on non-REM sleep is provided in Figure 13.1.



Within non-REM sleep, fMRI studies reported brain activations associated with the major neural rhythms that define this sleep stage: spindles and slow waves. Spindles—prominent during stage N2—were correlated with increased brain responses in the lateral and posterior aspects of the thalamus, in agreement with the central role of several thalamic nuclei (reticular thalamic and thalamocortical neurons) in the generation of spindles.2 Spindles were also associated with activation of specific paralimbic (anterior cingulate cortex, insula) and neocortical (superior temporal gyrus) areas. The hypothesis of two spindle subtypes—slow (11 to 13 Hz) and fast (13 to 15 Hz)—with distinct neural correlates was also explored with fMRI. It was observed that slow spindles exhibited a network very close to the “total” spindle one. In contrast, fast spindles were associated with a more diffuse cortical activation extending to somatosensory areas and mid–cingulate cortex. These neural correlates of sleep spindles with fMRI are shown in Figure 13.2. Slow waves, on the other hand, were associated with enhanced brain responses in inferior and medial aspects of the prefrontal cortex, a major site for slow wave initiation as corroborated by electrophysiological data. Other activations correlated with slow waves were located in parahippocampal gyrus, precuneus, posterior cingulate cortex, cerebellum, and brainstem.3 The neural correlates of sleep slow waves are summarized in Figure 13.3. Altogether these fMRI studies have identified brain regions involved in the generation, propagation, or modulation of non-REM sleep oscillations.





REM Sleep and Dreaming


The brain imaging knowledge about human dreaming derives from the neurobiological study of REM sleep, during which dreams are prominent. Brain activity during REM sleep—as consistently demonstrated by PET studies—is dominated by increased rCBF in the pons, thalamus, temporo-occipital, and limbic/paralimbic areas (including amygdala, hippocampal formation, and anterior cingulate cortex), along with a relatively decreased rCBF in dorsolateral prefrontal and inferior parietal cortices. Of note, these results are in good agreement with animal neurophysiological data on REM sleep generation, in particular with ponto-geniculo-occipital waves. The existence of these rhythms, initially described from electrophysiological recordings in cats, is strongly suggested in humans by both PET and fMRI studies of REM sleep.


Combined with neuropsychological findings in brain-damaged patients, those patterns might also explain several hallmarks of dreaming experience that are found in dream reports after awakening from REM sleep.4 For example, the increased activity in the amygdala is consistent with the predominance of threat-related emotions in dreams. Temporo-occipital increased activity is in keeping with visual dream imagery, which constitutes most of the sensorial experiment while dreaming. Also, prefrontal deactivation is evocative of the alteration in time perception, the lack of orientational stability, the delusional belief of being awake, the fragmented episodic memory recall, and the decrease in volitional control experienced in dreams. Finally, inferior parietal deactivation might contribute to the lack of distinction between first- and third-person perspectives, which is a core characteristic of the dream scenario. A summary of the neural correlates of REM sleep and dreaming is provided in Figure 13.4.




Obstructive Sleep Apnea


Neuroimaging studies have particularly addressed the neuropsychological damages induced by OSA. Structural alterations were found in the prefrontal cortex, hippocampal and parietal cortex in OSA patients before treatment, compared to controls. In these regions MRI using VBM found decreases of gray matter.5 Several of those abnormal patterns were, however, reversible under continuous positive airway pressure (CPAP) treatment for 3 months. Structural changes were paralleled by impairments in various cognitive functions, which were improved after CPAP. Interestingly, posttreatment improvements in neuropsychological scores were correlated with posttreatment increases in gray matter, particularly in the hippocampus (Fig. 13.5).



Although the fundamental pathophysiological mechanisms are not fully understood, a central dysregulation of the autonomic nervous system might participate in these processes. For instance, during respiratory maneuvers (Valsalva), altered fMRI signals were shown in OSA patients compared to controls. These abnormal activations were located in the cerebellar cortex and deep nuclei; superior frontal, precentral, cingulate, inferior parietal, superior temporal, and insular cortices; hippocampus; and midbrain. These data suggest a dysfunction of neural structures integrating afferent airway signals with autonomic and somatic responses.6


It is important to notice that peripheral factors might confound the deficits observed in studies focused on OSA patients, including, for example, exaggerated body mass index and motivational problems. Interestingly, overlaps of structural and functional deficits in the hippocampus, anterior cingulate, and frontal cortex (areas consistently showing abnormal structure or function in the depression literature) provide several potential biological links between OSA and mood disorders.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 16, 2016 | Posted by in NEUROLOGY | Comments Off on Neuroimaging Techniques

Full access? Get Clinical Tree

Get Clinical Tree app for offline access